WhaleCreep

Which hedge funds own 8IN? SYNEOS HEALTH INC, Q2 2026 13F holders

0 tracked hedge funds disclosed a position in 8IN (SYNEOS HEALTH INC) in their Q2 2026 13F filings, worth $0 in total.

0
Holders
0
New this quarter
0
Exited this quarter
$0
Combined value
–
Share of managers holding

Holders, Q2 2026

0 rows

Ownership over time

By quarter
QuarterHoldersManagers filingShare holdingCombined value
Q3 20230730.0%$0
Q2 202387311.0%$415m
Q1 20236738.2%$60.0m
Q4 20221731.4%$3.6m
Q3 20222742.7%$14.7m
Q2 20223744.1%$46.9m
Q1 20222742.7%$34.4m
Q4 20212742.7%$81.7m
Q3 20212712.8%$19.2m
Q2 20213714.2%$34.7m
Q1 20211701.4%$3.5m
Q4 20203714.2%$45.5m
Q3 20205687.4%$23.1m
Q2 20203684.4%$68.9m
Q1 20201681.5%$6.3m
Q4 20190670.0%$0
Q3 20192603.3%$45.7m
Q2 20193605.0%$117m
Q1 20194606.7%$144m
Q4 20181601.7%$69.1m
Q3 20183595.1%$110m
Q2 20183595.1%$143m
Q1 20184596.8%$90.2m

Who discovered 8IN first?

Earliest meaningful positions among the 15 tracked managers seen opening 8IN since Q1 2018.

2 rows
Rubric Capital Management LPQ1 20180.4%3.5%3Exited by Q2 2019+46%
Pentwater Capital Management LPQ1 20230.05%1.0%2Exited by Q3 2023+18%

Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.